Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APHA NASDAQ:CGC NASDAQ:CRON OTCMKTS:STDAF NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ACGCCanopy Growth$1.37-0.7%$1.31$0.77▼$5.80$330.99M0.7721.99 million shs9.89 million shsCRONCronos Group$2.62-1.9%$2.36$1.60▼$2.77$1.02B1.132.60 million shs2.21 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$1.21-4.0%$0.97$0.35▼$1.85$1.39B2.0357.60 million shs32.58 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%CGCCanopy Growth-0.72%0.00%+13.22%+10.48%-71.28%CRONCronos Group-1.87%+3.56%+8.26%+40.86%+15.42%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands-3.97%+8.04%+14.15%+236.11%-32.78%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ACGCCanopy Growth$1.37-0.7%$1.31$0.77▼$5.80$330.99M0.7721.99 million shs9.89 million shsCRONCronos Group$2.62-1.9%$2.36$1.60▼$2.77$1.02B1.132.60 million shs2.21 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$1.21-4.0%$0.97$0.35▼$1.85$1.39B2.0357.60 million shs32.58 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%CGCCanopy Growth-0.72%0.00%+13.22%+10.48%-71.28%CRONCronos Group-1.87%+3.56%+8.26%+40.86%+15.42%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands-3.97%+8.04%+14.15%+236.11%-32.78%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/ACGCCanopy Growth 1.33SellN/AN/ACRONCronos Group 0.00N/AN/AN/ASTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.33Hold$1.9460.12% UpsideCurrent Analyst Ratings BreakdownLatest CGC, STDAF, APHA, CRON, and TLRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025TLRYTilray BrandsJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$1.50 ➝ $2.008/12/2025CGCCanopy GrowthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 9/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphria$405.96M12.00$0.09 per share166.43$4.80 per share3.20CGCCanopy Growth$225.65M1.46N/AN/A$1.90 per share0.72CRONCronos Group$117.61M8.53$0.00 per share5,737.99$2.90 per share0.90STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$821.31M1.62$0.14 per share8.72$1.40 per share0.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphria-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/ACGCCanopy Growth-$429.86M-$3.03N/AN/AN/A-155.76%-89.93%-44.24%11/14/2025 (Estimated)CRONCronos Group$41.08M$0.0552.4087.33N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)Latest CGC, STDAF, APHA, CRON, and TLRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q1 2026TLRYTilray Brands-$0.03N/AN/AN/A$205.75 millionN/A8/8/2025Q1 2026CGCCanopy Growth-$0.15-$0.14+$0.01-$0.16$64.98 million$52.98 million8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/ACGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria0.252.361.17CGCCanopy Growth0.593.072.12CRONCronos GroupN/A24.6523.53STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.202.461.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphria10.30%CGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/ACGCCanopy Growth0.16%CRONCronos Group7.30%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/AOptionableCGCCanopy Growth3,150239.85 million239.47 millionOptionableCRONCronos Group450382.89 million354.94 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableCGC, STDAF, APHA, CRON, and TLRY HeadlinesRecent News About These CompaniesTilray Brands (NASDAQ:TLRY) Shares Down 4% - Here's WhySeptember 19 at 6:06 PM | marketbeat.comCannabis Stocks Worth Watching - September 19thSeptember 19 at 1:03 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Up 5.9% - Here's What HappenedSeptember 18 at 6:42 PM | marketbeat.comTop Cannabis Stocks To Watch Today - September 18thSeptember 18 at 1:14 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Trading Down 2.5% - Time to Sell?September 17 at 7:54 PM | marketbeat.comTilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to NoteSeptember 17 at 7:01 PM | zacks.comBest Cannabis Stocks To Consider - September 17thSeptember 17 at 1:09 PM | marketbeat.comTilray stock price sits and waits for Trump cannabis reschedulingSeptember 17 at 11:02 AM | invezz.comITilray Brands Inc. Unveils BC Selects: A New Line of Limited-Edition Premium Cannabis from Broken CoastSeptember 17 at 7:50 AM | quiverquant.comQBroken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream ReleaseSeptember 17 at 7:00 AM | globenewswire.comTilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of "Hold" from AnalystsSeptember 17 at 4:17 AM | marketbeat.comTilray Brands (TLRY) Is Down 5.9% After DOJ Rule SetbackSeptember 16, 2025 | finance.yahoo.comBest Cannabis Stocks To Watch Now - September 16thSeptember 16, 2025 | marketbeat.comBreckenridge Brewery Awarded Silver Certification By The Colorado Green Business NetworkSeptember 16, 2025 | insidermonkey.comBest Canadian Marijuana Stocks for Traders and Investors Right NowSeptember 16, 2025 | marijuanastocks.comMHop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon DucksSeptember 16, 2025 | globenewswire.comBest Cannabis Stocks To Keep An Eye On - September 15thSeptember 15, 2025 | marketbeat.comTop Cannabis Stocks To Watch Today - September 14thSeptember 15, 2025 | marketbeat.comCannabis Stocks To Research - September 13thSeptember 14, 2025 | marketbeat.comPromising Cannabis Stocks To Consider - September 12thSeptember 13, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Gap Up - Should You Buy?September 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20252 Data Center REITs That Look Good in Any PortfolioBy Sam Quirke | September 8, 2025Tilray's High Hopes: The Catalyst Driving Cannabis StocksBy Jeffrey Neal Johnson | August 21, 2025Why Micron Stock Could Outperform NVIDIA in 2025By Gabriel Osorio-Mazilli | September 12, 2025CGC, STDAF, APHA, CRON, and TLRY Company DescriptionsAphria NASDAQ:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Canopy Growth NASDAQ:CGC$1.37 -0.01 (-0.72%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.38 +0.00 (+0.36%) As of 09/19/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.62 -0.05 (-1.87%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.61 -0.01 (-0.38%) As of 09/19/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$1.21 -0.05 (-3.97%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.23 +0.02 (+1.24%) As of 09/19/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas FedEx Delivers Good News: The Bottom Is in for This Stock Tesla: 2 Reasons to Love Musk's $1B Buy, 1 Reason to Be Bearish Azure Leads While AI Excitement Fuels Microsoft Stock The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Darden Restaurants: A Textbook Buy-the-Dip Opportunity McDonald’s: New All-Time Highs Are Inevitable Workday Rising… To Fresh Record High Stock Prices 3 Reasons Amazon Could Be at an All-Time High by October Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
